Protalix Biotherapeutics, Inc.(NYSE Amex Equities : PLX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Services » Servicestothe Health Industry
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics, Inc. | -5.36% | 73.30 | 4.3% | $203.44m | |
| LH | Laboratory Corp. of America Holdings | -2.51% | 113.10 | 2.4% | $162.37m | |
| SYNH | Syneos Health, Inc. | -1.94% | 34.32 | 0.0% | $38.26m | |
| NRC | National Research Corp. | -5.62% | 42.29 | 0.0% | $2.00m | |
| AMEH | Apollo Medical Holdings, Inc. | -2.10% | 12.14 | 0.0% | $1.03m | |
| PLX | Protalix Biotherapeutics, Inc. | 0.91% | 2.21 | 56.8% | $0.28m | |
| IDXG | Interpace Biosciences, Inc. | -7.98% | 4.50 | 24.1% | $0.25m | |
| PMD | Psychemedics Corp. | -3.71% | 5.45 | 0.7% | $0.16m | |
| BASI | Bioanalytical Systems, Inc. | 4.05% | 3.34 | 0.2% | $0.07m |
Company Profile
Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.